He Du
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Venous Thromboembolism Diagnosis and Management 8
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Wei Xiong (11 shared papers)Yunfeng Zhao (8 shared papers)Xuejun Guo (5 shared papers)Youwei Zhang (3 shared papers)Sanyuan Sun (2 shared papers)Mei Xu (9 shared papers)Honggang Yu (1 shared paper)Bi Chen (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Respiratory Research (2 papers)BMJ Open Respiratory Research (2 papers)Thrombosis Journal (2 papers)Journal of Molecular and Cellular Cardiology (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
He Du
27 papers receiving 349 citations
Peers
Comparison fields: 5 of 60
- Internal Medicine 45
- Cancer Research 77
- Immunology 64
- Oncology 71
- Molecular Biology 156
Countries citing papers authored by He Du
This map shows the geographic impact of He Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Du more than expected).
Fields of papers citing papers by He Du
This network shows the impact of papers produced by He Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Du. The network helps show where He Du may publish in the future.
Co-authors
The 25 scholars most cited alongside He Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 63 | |
| 2 | 2021 | 40 | |
| 3 | 2019 | 38 | |
| 4 | 2011 | 36 | |
| 5 | 2021 | 24 | |
| 6 | 2021 | 20 | |
| 7 | 2020 | 18 | |
| 8 | 2020 | 16 | |
| 9 | 2016 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 6 | |
| 16 | [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation]. | 2010 | 6 |
| 17 | Distinct Prognostic Values of the mRNA Expression of Glucose Transporters in Non-Small Cell Lung Cancer. | 2020 | 5 |
| 18 | 2019 | 5 | |
| 19 | 2016 | 5 | |
| 20 | 2020 | 4 |
About He Du
He Du is a scholar working on Internal Medicine, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, having authored 29 papers that have together received 353 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (8 papers), Cancer-related molecular mechanisms research (3 papers), Lung Cancer Research Studies (2 papers), RNA modifications and cancer (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), MicroRNA in disease regulation (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Internal Medicine (45 citations), Cancer Research (77 citations), Immunology (64 citations), Oncology (71 citations) and Molecular Biology (156 citations). He Du has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Wei Xiong, Yunfeng Zhao, Xuejun Guo, Youwei Zhang, Sanyuan Sun, Mei Xu, Honggang Yu, Bi Chen, Guoan Xiang and Qian Zhang. Their work appears in journals such as Frontiers in Oncology, Respiratory Research, BMJ Open Respiratory Research, Thrombosis Journal and Journal of Molecular and Cellular Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.